A Global Perspective on Biomarkers in Gastrointestinal Cancer

In this interactive webcast, experts discuss how the latest data on the use of biomarker-driven treatments for patients with gastrointestinal cancers affects their clinical practice.

David H. Ilson, MD, PhD John L. Marshall, MD Eric Van Cutsem, MD, PhD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: August 16, 2021 Expired: August 15, 2022

Download this slideset for expert perspectives on best practices in testing for MSI/MMR, TMB, PD-L1, and NTRK fusions and using immune checkpoint and TRK inhibitors for patients with GI cancers.

John L. Marshall, MD Released: July 15, 2021

Download this slideset to learn how experts approach biomarker testing and leverage testing results to inform treatment strategies for patients with advanced CRC.

Eric Van Cutsem, MD, PhD Released: July 15, 2021

Download this slideset to learn how experts approach biomarker testing and leverage testing results to inform treatment strategies for patients with advanced pancreatic, biliary tract, and gastroesophageal cancers.

David H. Ilson, MD, PhD Released: July 15, 2021

Download this short summary slideset of key takeaway points on how experts approach biomarker testing and leverage testing results to inform targeted treatment strategies for patients with advanced gastrointestinal cancers.

David H. Ilson, MD, PhD John L. Marshall, MD Eric Van Cutsem, MD, PhD Released: July 23, 2021